Endoscopic ultrasound : a new look at achalasia?HATLEBAKK, J. G; ØDEGAARD, S.European journal of gastroenterology & hepatology. 1998, Vol 10, Num 7, pp 543-545, issn 0954-691XArticle

Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitisHATLEBAKK, J. G; BERSTAD, A.Scandinavian journal of gastroenterology. 1996, Vol 31, Num 10, pp 954-958, issn 0036-5521Article

Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazoleHATLEBAKK, J. G; BERSTAD, A.Alimentary pharmacology & therapeutics. 1997, Vol 11, Num 6, pp 1093-1099, issn 0269-2813Article

Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux diseaseHATLEBAKK, J. G; BERSTAD, A.Clinical pharmacokinetics. 1996, Vol 31, Num 5, pp 386-406, issn 0312-5963Article

Dysphagie au cours du reflux gastro-oesophagien avant chirurgie : Les dysphagies = Dysphagia in the course of gastro-oesophageal reflux before surgeryPICHE, T; HATLEBAKK, J. G.Acta endoscopica. 2006, Vol 36, Num 4, pp 545-554, issn 0240-642X, 10 p.Article

Endoscopic grading of reflux oesophagitis: What observations correlate with gastro-oesophageal reflux?HATLEBAKK, J. G; BERSTAD, A.Scandinavian journal of gastroenterology. 1997, Vol 32, Num 8, pp 760-765, issn 0036-5521Article

Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitisHATLEBAKK, J. G; BERSTAD, A.Alimentary pharmacology & therapeutics. 1997, Vol 11, Num 2, pp 365-372, issn 0269-2813Article

The effect of helicobacter pylori eradication on gastro-oesophageal refluxTEFERA, S; HATLEBAKK, J. G; BERSTAD, A et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 7, pp 915-920, issn 0269-2813Article

Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcersOLAFSSON, S; HATLEBAKK, J. G; BERSTAD, A et al.Scandinavian journal of gastroenterology. 2002, Vol 37, Num 12, pp 1386-1394, issn 0036-5521, 9 p.Article

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazoleKATZ, P. O; HATLEBAKK, J. G; CASTELL, D. O et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 6, pp 709-714, issn 0269-2813Article

Gastric accommodation studied by ultrasonography in patients with reflux esophagitisTEFERA, S; GILJA, O. H; HATLEBAKK, J. G et al.Digestive diseases and sciences. 2001, Vol 46, Num 3, pp 618-625, issn 0163-2116Conference Paper

Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburnJOHNSSON, F; HATLEBAKK, J. G; KLINTENBERG, A.-C et al.Scandinavian journal of gastroenterology. 2003, Vol 38, Num 4, pp 347-353, issn 0036-5521, 7 p.Article

Eradication of Helicobacter pylori does not increase acid reflux in patients with mild to moderate reflux oesophagitisTEFERA, S; HATLEBAKK, J. G; ELNAES BERSTAD, A et al.Scandinavian journal of gastroenterology. 2002, Vol 37, Num 8, pp 877-883, issn 0036-5521Article

Gastroesophageal reflux in morbidly obese patients treated with gastric banding or vertical banded gastroplastyØVREBØ, K. K; HATLEBAKK, J. G; VISTE, A et al.Annals of surgery. 1998, Vol 228, Num 1, pp 51-58, issn 0003-4932Article

Intragastric maldistribution of a liquid meal in patients with reflux oesophagitis assessed by three dimensional ultrasonographyTEFERA, S; GILJA, O. H; OLAFSDOTTIR, E et al.Gut. 2002, Vol 50, Num 2, pp 153-158, issn 0017-5749Article

Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-upBERSTAD, A; BERSTAD, K; WILHELMSEN, I et al.Alimentary pharmacology & therapeutics. 1995, Vol 9, Num 2, pp 197-200, issn 0269-2813Article

Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer diseaseHATLEBAKK, J. G; NESJE, L. B; HAUSKEN, T et al.Scandinavian journal of gastroenterology. 1995, Vol 30, Num 11, pp 1053-1057, issn 0036-5521Article

Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERDJONASSON, C; MOUM, B; BANG, C et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 11, pp 1290-1300, issn 0269-2813, 11 p.Article

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. Commentary. Author's replyLUNDELL, L; MIETTINEN, P; WIKLUND, I et al.Journal of the American College of Surgeons. 2001, Vol 192, Num 2, pp 172-181, issn 1072-7515Conference Paper

Heartburn treatment in primary care : randomised, double blind study for 8 weeksHATLEBAKK, J. G; HYGGEN, A; MADSEN, P. H et al.BMJ. British medical journal (International ed.). 1999, Vol 319, Num 7209, pp 550-553, issn 0959-8146Article

Ineffective esophageal motility : The most common motility abnormality in patients with GERD-associated respiratory symptomsFOUAD, Y. M; KATZ, P. O; HATLEBAKK, J. G et al.The American journal of gastroenterology. 1999, Vol 94, Num 6, pp 1464-1467, issn 0002-9270Article

Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazoleOLAFSSON, S; BERSTAD, A; BANG, C. J et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 5, pp 651-659, issn 0269-2813Article

Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg dailyHATLEBAKK, J. G; KATZ, P. O; KUO, B et al.Alimentary pharmacology & therapeutics. 1998, Vol 12, Num 12, pp 1235-1240, issn 0269-2813Article

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis : results of a Scandinavian multicentre trialHATLEBAKK, J. G; BERSTAD, A; KITTANG, E et al.Scandinavian journal of gastroenterology. 1993, Vol 28, Num 3, pp 224-228, issn 0036-5521Article

Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux diseaseJONASSON, C; WERNERSSON, B; HOFF, D. A. L et al.Alimentary pharmacology & therapeutics. 2013, Vol 37, Num 5, pp 564-572, issn 0269-2813, 9 p.Article